Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Syner-Med is a UK-based pharmaceutical company that specializes in the marketing and distribution of prescription medicines and medical devices. Founded in 1995, the company focuses on delivering niche and innovative treatments across therapeutic areas such as nephrology, gastroenterology, oncology, and pain management. Syner-Med acts as a strategic partner for international pharmaceutical firms looking to enter or expand within the UK and Irish healthcare markets. Their portfolio includes specialized products for iron deficiency, phosphate binding in chronic kidney disease, and topical anesthesia. The company is recognized for its expertise in navigating the regulatory and market access landscape for specialty pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Syner-Med.